Completed OBSERVATIONAL NCT03147391

Left Atrial Appendage Closure With the LAmbre

Percutaneous Left Atrial Appendage Closure Using the LAmbre Device in Patients With Atrial Fibrillation: a Single-center, Retrospective, Long-term Real-world Study

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.

Conditions Atrial Fibrillation Left Atrial Appendage Closure Stroke

Interventions LAA closure with LAmbre

Updated 6 times since 2017 Last updated: May 6, 2017 Started: Apr 14, 2014 Primary completion: Nov 30, 2016 Completion: May 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Atrial Fibrillation and Left Atrial Appendage Closure, this trial is completed. The trial is conducted by Lifetech Scientific (Shenzhen) Co., Ltd. and has accumulated 6 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jul 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lifetech Scientific (Shenzhen) Co., Ltd.
Shanghai 10th People's Hospital

Data source: Shanghai 10th People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.